vorinostat has been researched along with EBV Infections in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "SAHA inhibited tumor progression and metastasis in the murine xenograft model." | 1.40 | Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma. ( Fujiwara, S; Goshima, F; Imadome, K; Iwata, S; Kanazawa, T; Kimura, H; Murata, T; Nakagawa, H; Siddiquey, MN; Suzuki, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siddiquey, MN | 1 |
| Nakagawa, H | 1 |
| Iwata, S | 1 |
| Kanazawa, T | 1 |
| Suzuki, M | 1 |
| Imadome, K | 1 |
| Fujiwara, S | 1 |
| Goshima, F | 1 |
| Murata, T | 1 |
| Kimura, H | 1 |
| Hui, KF | 1 |
| Ho, DN | 1 |
| Tsang, CM | 1 |
| Middeldorp, JM | 1 |
| Tsao, GS | 1 |
| Chiang, AK | 1 |
| Smeltzer, JP | 1 |
| Viswanatha, DS | 1 |
| Habermann, TM | 1 |
| Patnaik, MM | 1 |
3 other studies available for vorinostat and EBV Infections
| Article | Year |
|---|---|
Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Disease Progres | 2014 |
Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Proliferation; Epstein | 2012 |
Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Epstein-Barr Virus Infections; Female; Humans; Hydro | 2012 |